Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) Short Interest Update

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) saw a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 4 shares, a drop of 96.2% from the July 15th total of 106 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 100 shares, the short-interest ratio is currently 0.0 days.

Ambu A/S Stock Performance

Ambu A/S stock remained flat at $10.86 during trading hours on Tuesday. The firm’s fifty day moving average price is $10.04 and its 200-day moving average price is $10.87. The stock has a market cap of $2.55 billion, a PE ratio of 38.79 and a beta of 0.93. Ambu A/S has a 1 year low of $8.54 and a 1 year high of $16.78. The company has a quick ratio of 1.73, a current ratio of 2.92 and a debt-to-equity ratio of 0.08.

Ambu A/S Company Profile

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.